Clinical Trial Update: Study of Gemcabene in Adults With FPLD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates for gemcabene in adults with familial partial lipodystrophy (FPLD) and hypertriglyceridemia have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Partial Lipodystrophy
• Hypertriglyceridemia
• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• gemcabene (gemcabene)

Snippet

Sponsor: Elif Oral | Conditions: Familial Partial Lipodystrophy, Hypertriglyceridemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-08-17